Drug intelligence / Profile preview

Qishen'gubiao Granule

Development stage
Unknown
Lead developer
Hubei Mengyang Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Qishen'gubiao Granule is a traditional Chinese medicine (TCM) preparation composed of nine herbs. It has been widely used for the prevention and treatment of coronavirus disease 2019 (COVID-19) and chronic heart failure (CHF). The granules are prepared by water extraction followed by alcohol sedimentation, resulting in a botanical drug formulation. Clinical studies have shown that Qishen'gubiao Granules can improve cardiac function in CHF patients by reducing N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels, improving New York Heart Association functional classification, increasing 6-minute walking distance, and enhancing quality of life measures. For COVID-19, network pharmacology and molecular docking studies suggest that active compounds such as quercetin, apigenin, scutellarein, luteolin, and naringenin target key proteins including angiotensin-converting enzyme 2 and 3-chymotrypsin-like protease to modulate immune and inflammatory pathways. The product is manufactured as granules with lactose excipient for oral administration.

Brand names
Qishen Gubiao granulesQishen Gubiao Keli芪参固表颗粒
Other names
Qishen Gubiao granulesQSG
02

Targets

ACE2 (Angiotensin-converting enzyme 2)Mpro (3C-like proteinase of SARS-CoV-2)

Beyond the preview

Go deeper on Qishen'gubiao Granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qishen'gubiao Granule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call